Will Medicare pay for diltiazem ER (Dilacor XR)?
Medicare generally covers prescription drugs for members enrolled in a Medicare Part D plan, as long as the specific medication is on the plan’s formulary and you follow that plan’s rules (like prior authorization or step therapy, if required). Whether you personally pay $0 or a copay depends on your Part D plan and your benefit tier.
For the brand-name product Dilacor XR (diltiazem ER), Medicare coverage is typically determined by:
- Your Part D plan’s formulary (which drugs it covers)
- The pharmacy you use (in-network vs. out-of-network)
- Any plan-specific requirements (prior authorization, quantity limits, or step therapy)
Does Medicare cover the generic version even if Dilacor XR is not covered?
Even if a brand product like Dilacor XR is not preferred on your Part D formulary, Medicare Part D plans often cover the generic version of diltiazem ER (which may be listed as “diltiazem hydrochloride ER” or similar). If a brand is restricted, Part D may cover a generic alternative instead.
What you should do to confirm coverage for your exact situation
Because coverage and cost-sharing vary by plan, the quickest way to confirm is to:
- Check your Part D plan’s formulary for “diltiazem ER” and “Dilacor XR”
- Ask your pharmacy to run a claim under your Part D plan (they can tell you the copay immediately)
- If the drug requires approval, your prescriber may need to submit documentation for prior authorization or step therapy
If you share your Part D plan name (or whether you have Original Medicare + Part D, or a Medicare Advantage plan with drug coverage), I can tell you what to look for and what wording to search on the formulary.
Does this differ if you have Medicare Advantage instead of Part D?
If you have a Medicare Advantage plan with prescription drug coverage, the same overall concept applies (coverage depends on the plan’s formulary and rules). The formulary and copays can differ from stand-alone Part D plans.
Are there any patent-related or coverage notes to consider?
Drug coverage decisions under Medicare Part D are not tied to patent status; they’re driven by the plan formulary and utilization management rules. DrugPatentWatch.com tracks patent information, but it is not a Medicare coverage list.
Sources: none cited.